LUCHINI, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 14.060
EU - Europa 11.497
AS - Asia 9.481
SA - Sud America 1.757
Continente sconosciuto - Info sul continente non disponibili 795
AF - Africa 389
OC - Oceania 27
Totale 38.006
Nazione #
US - Stati Uniti d'America 13.604
RU - Federazione Russa 4.720
SG - Singapore 3.750
CN - Cina 2.432
IT - Italia 1.878
GB - Regno Unito 1.727
BR - Brasile 1.372
HK - Hong Kong 987
VN - Vietnam 873
DE - Germania 615
IE - Irlanda 573
FR - Francia 546
SE - Svezia 471
BD - Bangladesh 371
FI - Finlandia 294
KR - Corea 294
CA - Canada 226
IN - India 152
NL - Olanda 145
AR - Argentina 137
JP - Giappone 121
MX - Messico 106
UA - Ucraina 97
TR - Turchia 78
NG - Nigeria 73
ID - Indonesia 72
AT - Austria 70
EC - Ecuador 69
ES - Italia 68
ZA - Sudafrica 64
BJ - Benin 60
PL - Polonia 59
TG - Togo 54
IQ - Iraq 53
VE - Venezuela 43
BE - Belgio 39
CO - Colombia 34
MA - Marocco 34
PK - Pakistan 34
CL - Cile 29
PH - Filippine 28
PY - Paraguay 28
UZ - Uzbekistan 28
JM - Giamaica 23
SA - Arabia Saudita 23
CZ - Repubblica Ceca 22
MY - Malesia 22
CH - Svizzera 21
KE - Kenya 21
AU - Australia 20
PE - Perù 19
TN - Tunisia 19
CR - Costa Rica 18
HR - Croazia 16
AE - Emirati Arabi Uniti 15
JO - Giordania 15
LT - Lituania 13
NI - Nicaragua 13
AL - Albania 12
AZ - Azerbaigian 12
EG - Egitto 12
IR - Iran 12
LV - Lettonia 12
NP - Nepal 12
UY - Uruguay 12
BO - Bolivia 11
KZ - Kazakistan 11
OM - Oman 11
PT - Portogallo 11
DZ - Algeria 10
HN - Honduras 10
RO - Romania 10
RS - Serbia 10
SK - Slovacchia (Repubblica Slovacca) 10
KG - Kirghizistan 9
SV - El Salvador 9
TH - Thailandia 9
IL - Israele 8
BY - Bielorussia 7
LB - Libano 7
NO - Norvegia 7
PS - Palestinian Territory 7
SN - Senegal 7
CY - Cipro 6
DO - Repubblica Dominicana 6
EE - Estonia 6
ET - Etiopia 6
GT - Guatemala 6
HU - Ungheria 6
SI - Slovenia 6
TT - Trinidad e Tobago 6
AM - Armenia 5
BB - Barbados 5
DK - Danimarca 5
PR - Porto Rico 5
AO - Angola 4
BG - Bulgaria 4
GA - Gabon 4
MK - Macedonia 4
NZ - Nuova Zelanda 4
Totale 37.124
Città #
Singapore 1.856
Ashburn 1.779
San Jose 1.667
Moscow 1.583
Dallas 1.477
Southend 1.351
Chandler 1.046
Hong Kong 939
Verona 761
Council Bluffs 606
Dublin 543
Beijing 508
The Dalles 481
New York 394
Jacksonville 292
Ho Chi Minh City 286
Woodbridge 269
Los Angeles 261
Ann Arbor 203
Houston 198
Santa Clara 192
Princeton 182
Lawrence 181
Munich 178
Hanoi 175
Wilmington 148
São Paulo 143
Buffalo 134
Milan 132
Helsinki 124
Redondo Beach 123
Jinan 118
Nanjing 112
London 106
Columbus 104
Tokyo 102
Shenyang 91
Redmond 86
Sindelfingen 82
Rome 78
Montreal 74
Abuja 71
Seattle 71
Orem 69
Phoenix 64
Hebei 61
Cotonou 60
Tianjin 58
Turku 58
Chicago 55
Guangzhou 55
Zhengzhou 55
Lomé 54
Amsterdam 52
Atlanta 52
Rio de Janeiro 51
Toronto 50
Warsaw 50
Brooklyn 49
Ningbo 49
Changsha 48
Da Nang 48
Redwood City 47
Hangzhou 46
Nuremberg 46
Bologna 45
Seoul 45
Frankfurt am Main 44
Johannesburg 43
Shanghai 42
Stockholm 42
Taizhou 42
Vienna 40
Brussels 39
Haikou 39
San Francisco 39
Washington 39
Denver 38
Taiyuan 38
Chennai 37
Haiphong 37
Lancaster 37
McKinney 36
Mexico City 36
Nanchang 35
Naples 35
Lappeenranta 33
Paris 33
Poplar 33
Belo Horizonte 30
Brasília 30
Falkenstein 29
Jakarta 29
Jiaxing 28
Florence 27
Madrid 26
Cleveland 25
Boardman 24
Boston 24
Mumbai 23
Totale 21.706
Nome #
Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis 303
Genomic characterization of hepatoid tumors: context matters 272
A rare case of three different tumors in the same pancreatic specimen: a case report and brief review of the literature 264
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 259
Tumor-like lesionsof the pancreas. 246
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing 246
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 234
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 229
CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas 226
Adherence to the Mediterranean diet is associated with better quality of life: data from the Osteoarthritis Initiative 221
Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature 220
Adenocarcinoma of the paraurethral glands: a case report 220
Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis 215
Sex differences in oncogenic mutational processes 214
Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment 213
CD71 in Gestational Pathology: A Versatile Immunohistochemical Marker With New Possible Applications 213
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 211
Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysis 210
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 207
Different Prognostic Roles Of Tumor Suppressor Gene BAP1 In Cancer: A Systematic Review With Meta-Analysis 206
Ampulla of Vater carcinoma: Molecular landscape and clinical implications 206
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 204
Artificial neural networks for multi-omics classifications of hepato-pancreato-biliary cancers: towards the clinical application of genetic data 202
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 202
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 202
Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis 200
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 199
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 197
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 197
Hypovitaminosis D and orthostatic hypotension: a systematic review and meta-analysis 196
Epstein-Barr Virus-associated gastric cancer: a histopathologic study with comprehensive molecular profiling 195
Efficacy and Toxicity Analysis of mFOLFIRINOX in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms 193
CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype 193
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 192
CD13 is a useful tool in the differential diagnosis of meningiomas with potential biological and prognostic implications 191
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 190
Epithelial-mesenchymal transition in undifferentiated carcinoma of the pancreas with and without osteoclast-like giant cells 190
Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma 188
Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis 187
Fhit down-regulation is an early event in pancreatic carcinogenesis 185
Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance 185
Tracheobronchopathia Osteochondroplastica: A Case Report Illustrating the Importance of Multilevel Workup Clinical, Endoscopic and Histological Assessment in Diagnosis of an Uncommon Disease 182
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications 181
Specific expression patterns of epithelial to mesenchymal transition factors in gestational molar disease 179
ARID1A mutational status in non-small cell lung cancer: from molecular pathology to clinical implications with a focus on the relationships with EGFR 175
Adherence to a Mediterranean diet is associated with lower prevalence of osteoarthritis: Data from the osteoarthritis initiative 175
Weight loss is associated with improvements in cognitive function among overweight and obese people: A systematic review and meta-analysis 175
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 175
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 175
Loss of FGFR4 promotes the malignant phenotype of PDAC 174
Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis 174
Ampullary Neuroendocrine Neoplasms: Identification of Prognostic Factors in a Multicentric Series of 119 Cases 174
Heterogeneity of predictive biomarker expression in gastric and esophago-gastric junction carcinoma with peritoneal dissemination 173
Pathological complete response in a patient affected by multiple synchronous, breast and lung primary malignancies: a case report and review of the literature 173
Extranodal extension in N1-adenocarcinoma of the pancreas and papilla of Vater: a systematic review and meta-analysis of its prognostic significance 172
Endoscopic ultrasound fine-needle biopsy to assess DAXX/ATRX expression and alternative lengthening of telomeres status in non-functional pancreatic neuroendocrine tumors 170
Surgery for pancreatic neuroendocrine tumors during the COVID-19 pandemic: a retrospective cohort from a high-volume center 170
High-risk Pancreatic Anastomosis vs. Total Pancreatectomy after Pancreatoduodenectomy: Postoperative Outcomes and Quality of Life Analysis 170
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 170
Extranodal extension is an important prognostic parameter for both colonic and rectal cancer 167
Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation 166
Exosomal miRNA signatures of pancreatic lesions 166
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants 166
ASO Visual Abstract: Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective Lymphadenectomy Protocol 166
Next-Generation Histopathologic Diagnosis: A Lesson From a Hepatic Carcinosarcoma 165
Serous Neoplasms 165
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas 163
Hepatoid tumors of the gastrointestinal/pancreatobiliary district: morphology, immunohistochemistry, and molecular profiles 163
Platinum-Based Treatment for Well- and Poorly Differentiated Pancreatic Neuroendocrine Neoplasms 163
Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma 162
CARATTERISTICHE CLINICO-PATOLOGICHE, PROFILO MOLECOLARE E BERSAGLI PER L’IMMUNOTERAPIA NEI CARCINOMI INDIFFERENZIATI DEL PANCREAS CON CELLULE GIGANTI SIMIL-OSTEOCLASTICHE 162
Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection 161
Metastatic malignant melanoma to the gallbladder. Case report and review of the literature 161
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 161
Either High or low Risk: The Acinar Score at the Resection Margin Dichotomizes the Risk Spectrum Of Pancreas-specific Complications After Pancreatoduodenectomy 160
Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis 160
From Genetic Alterations to Tumor Microenvironment: The Ariadne's String in Pancreatic Cancer 160
ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach 160
Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterization 159
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 159
Inflammatory and tumor-like lesions of the pancreas 159
Malignant epithelial/exocrine tumors of the pancreas 159
Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metastatic sites 159
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases 158
Amsterdam International Consensus Meeting: tumor response scoring in the pathology assessment of resected pancreatic cancer after neoadjuvant therapy 157
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities 157
Long-term organoid culture of a small intestinal neuroendocrine tumor 155
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 155
Artificial intelligence in oncology: current applications and future perspectives 154
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association 153
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 153
Circulating tumour DNA: a challenging innovation to develop "precision onco-surgery" in pancreatic adenocarcinoma 153
Acetylcholinesterase inhibitors and memantine in bipolar disorder: A systematic review and best evidence synthesis of the efficacy and safety for multiple disease dimensions 152
Mucinous Neoplasms 152
Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma 150
Artificial Intelligence for Predicting Microsatellite Instability Based on Tumor Histomorphology: A Systematic Review 150
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer 149
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial 149
Fatty pancreas disease: an integrated study on frozen tissues shows distinct compartments of inter/intra-lobular, intra-acinar, and intra-islet fat deposition 149
Evaluating Mismatch Repair Deficiency for Solid Tumor Immunotherapy Eligibility: Immunohistochemistry versus Microsatellite Molecular Testing 148
Totale 18.346
Categoria #
all - tutte 141.381
article - articoli 136.240
book - libri 0
conference - conferenze 687
curatela - curatele 0
other - altro 454
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.000
Totale 282.762


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022916 0 0 0 123 35 36 43 129 68 39 95 348
2022/20233.134 206 333 284 520 250 777 51 205 352 40 74 42
2023/20242.166 92 166 161 222 233 318 198 152 40 96 369 119
2024/20256.034 324 282 259 912 301 211 377 317 867 466 564 1.154
2025/202618.294 1.234 997 1.634 2.785 4.249 1.043 1.509 1.110 1.560 1.039 484 650
2026/20272.773 421 705 762 885 0 0 0 0 0 0 0 0
Totale 38.006